Transformation of primary myelofibrosis with 20q- in Philadelphia-positive acute lymphoblastic leukemia: Case report and review of literature

Pathology Research and Practice

Volumn 208, Issue 7, 2012, Pages 420-423

  Jurisic, Vladimir ^a   Colovic, Natasa ^b,c   Terzic, Tatjana ^b,c   Djordjevic, Vesna ^b   Colovic, Milica ^c  

^a UNIVERSITY OF KRAGUJEVAC   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

20q ; ALL; Cytogenetics; Immunophenotype; Mutation; Myelofibrosis; Philadelphia chromosome; Transformation

Indexed keywords

ANTIBIOTIC AGENT; BCR ABL PROTEIN; CD11B ANTIGEN; CD19 ANTIGEN; CD22 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; HLA DR ANTIGEN; PREDNISONE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BLOOD; CASE REPORT; CHROMOSOME 20Q; CHROMOSOME DELETION; CYTOGENETICS; FATIGUE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; LABORATORY TEST; MALAISE; MALE; MYELOFIBROSIS; MYELOID METAPLASIA; PHILADELPHIA CHROMOSOME POSITIVE CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLENOMEGALY; THROMBOCYTE TRANSFUSION;

CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 20; CYTOGENETIC ANALYSIS; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; PHILADELPHIA CHROMOSOME; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRIMARY MYELOFIBROSIS;

EID: 84863815856     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2012.04.007     Document Type: Article

References (18)

1. Barosi G. Myelofibrosis with myeloid metaplasia. Hematol. Oncol. Clin. North Am. 2003, 17:1211-1226.
2. Fenaux P., Morel P., Lai J.L. Cytogenetics of myelodysplastic syndromes. Semin. Hematol. 1996, 33:127-138.
3. Braun T., Stéphane de Botton S., Taksin A., Park S., Beyne-Rauzy O., Coiteux V., Sapena R., Lazareth A., Leroux G., Guenda K., Cassinat B., Fontenay M., Vey N., Guerci A., Dreyfus F., Bordessoule D., Stamatoullas A., Castaigne S., Terré C., Eclache V., et al. Characteristics and outcome of myelodysplastic syndromes (MDS) with isolated 20q deletion: a report on 62 cases. Leuk. Res. 2011, 35:863-867.
4. Heim S., Mitelman F. Cytogenetic analysis in the diagnosis of acute leukemia. Cancer 1992, 70:1701-1709.
5. Wadleigh M., Tefferi A. Classification and diagnosis of myeloproliferative neoplasms according to the 2008 World Healt Organization criteria. Int. J. Hematol. 2010, 91:174-179.
6. Gurvich N., Perna F., Farina A., Voza F., Menendez S., Hurwitz J., Nimer S.D. L3MBTL1 polycomb protein, a candidate tumor suppressor in del(20q12) myeloid disorders, is essential for genome stability. Proc. Natl. Acad. Sci. U.S.A. 2010, 107(52):22552-22557.
7. Hasserjian R.P. Deletion of chromosome 20q: friend or foe?. Leuk. Res. 2011, 35:844-845.
8. Hollings P.E., Benjes S.M., Rosman I., Fitzgerald P.H. Deletion 20q in association with Philadelphia chromosome positive acute lymphoblastic leukemia: report of two cases. Cancer Genet. Cytogenet. 1995, 79:32-35.
9. Crescenzi B., La Starza R., Sambani C., et al. Totipotent stem cells bearing del(20q) maintain multipotential differentiation in Shwachman Diamond syndrome. Br. J. Haematol. 2009, 144:116-119.
10. Nilsson T., Nilsson L., Lenhoff S., et al. MDS/AML-associated cytogenetic abnormalities in multiple myeloma and monoclonal gammopathy of undetermined significance: evidence for frequent de novo occurrence and multipotent stem cell involvement of del(20q). Genes Chromosomes Cancer 2004, 41:223-231.
11. Aimakopoulos F.A., Green R.A. Deletion of chromosome 20q and the pathogenesis of myeloproliferative disorders. Br. J. Haematol. 1996, 95:219-226.
12. Reeves B.R., Lobb D.S., Lawler S.D. Identity of abnormal F-group chromosome associated with polycythaemia vera. Humangenetik 1972, 14:159-161.
13. Cohen M., Ariel I., Dagan J. Chromosome deletion (46, XY,20q-) in sideroblastic anemia. Israel J. Med. Sci. 1974, 10:1393-1396.
14. Matano S., Nakamura S., Kobayashi K., Yoshida T., Matsuda T., Sugimoto T. Deletion of lonf arm of chromosome 20 in a patient with chronic neutrophilic leukemia: cytogenetic findings in chronic neutrophilic leukemia: cytogenetic findings in chronic neutrophilic leukemia. Am. J. Hematol. 1997, 54:72-75.
15. Whang-Peng J., Lee E., Knutsen T., Chang P., Nienhuis A. Cytogenetic studies in patients with myelosclerosis and myeloid metaplasia. Leuk. Res. 1977, 21:41-56.
16. Polliack A., Prokocimer M., Matzner Y. Lymphoblastic leukemic transformation (lymphoblastic crisis) in myelofibrosis and myeloid metaplasia. Am. J. Hematol. 1980, 9:211-220.
17. Shaheen S.P., Talwalker S.S., Simons R., Yam L. Acute lymphoblastic leukemic transformation in a patient with chronic idiopathic myelofibrosis and paroxysmal nocturnal hemoglobinuria: a case report and review of the literature. Arch. Pathol. Lab. Med. 2005, 129:96-99.
18. Fleischman E.W., Prigogina E.L., Volkova M.A., Kulagina O.E. Chromosomal marker 20q-, in cases of osteomyelosclerosis and CML. Hum. Genet. 1979, 50(1):101-104.